Bluefin Capital Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Bluefin Capital Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 16, 2024	BUY	$48.48 - $57.85 $2.55 Million - $3.04 Million	52,600 New	52,600 $2.7 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $10.6 Million - $12.8 Million	173,200 Added 643.87%	200,100 $890,000
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $1.54 Million - $1.71 Million	26,900 New	26,900 $30,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.